Bumetanide - NDC Database (Page 7)
67184-0594 Sep 19, 2024
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Qilu Pharmaceutical Co., Ltd.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Qilu Pharmaceutical Co., Ltd.
68083-496 May 26, 2022
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Gland Pharma Limited
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Gland Pharma Limited
68083-497 May 26, 2022
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Gland Pharma Limited
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Gland Pharma Limited
68462-469 Jan 01, 2023
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Glenmark Pharmaceuticals Inc., USA
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Glenmark Pharmaceuticals Inc., USA
68462-470 Jan 01, 2023
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Glenmark Pharmaceuticals Inc., USA
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Glenmark Pharmaceuticals Inc., USA
70748-323 Nov 11, 2024
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Lupin Pharmaceuticals, Inc.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Lupin Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.